~~<i id='2FD4033279'><strike id='2FD4033279'><tt id='2FD4033279'><pre id='2FD4033279'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

entertainment

author：focus 2025-09-27 09:45:16 - browse：1

An FDA sign — health policy coverage from STAT — Sarah Silbiger/Getty Images

WASHINGTON — There’s about to be a new acronym in town.

The Food and Drug Administration is in the final stages of cementing sweeping changes to the Office of Regulatory Affairs, which oversees inspections and compliance for all its regulated products, according to three people familiar with the planning.

That overhaul includes a new name: Meet the Office of Inspections and Investigations.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Doulas covered by Medicaid under New York's new plan

explore

focus

hotspot

entertainment

leisure time

knowledge

TheFDAhasapprovedModerna’sRSVvaccineforolderadults.ModernaTheFoodandDrugAdministrationonFridayapprov

WSS

Finland to offer bird flu vaccine to select groups of people, a possible global first

Caregivers of transplant patients call for more support, training

Eli Lilly’s Zepbound improved liver scarring in mid

Health and fitness trackers are measuring the wrong things

Senators tussle over abortion against the backdrop of a presidential campaign

Medicare Advantage's lean provider networks lead CMS complaints

explore

entertainment

explore

Medicare details structure of new drug price negotiation program

JPM 2024: FogPharma’s CEO unveils ‘contrarian’ plan in oncology

United colonoscopy coverage change 'may cost lives,' doctors say

FDA approves Moderna’s RSV vaccine, its second licensed product

23andMe had bad news about my health. I wish a person had delivered it

Risky weight loss products often used by teens globally, per study

Virginia high school admissions case could be legal follow

JPM 2024: Nvidia claims we're in biological revolution. Are we?

Psychedelics group wrestles with new pharma identity

Sutter Health’s antitrust win overturned by appeals court

focus

As JPM 2024 winds down, some health tech firms project optimism

ASCO Takeaways: Winners, snoozers, and the art of cancer care

Caregivers of transplant patients call for more support, training

The most pressing bird flu mysteries scientists want answered

Caregivers of transplant patients call for more support, training

Fauci’s Covid grilling leads GOP to weigh foreign research rules

hotspot

entertainment

leisure time

knowledge